Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001770390-26-000002

Chief Scientific Officer gave up 5,098 shares (to pay taxes)

  • Chief Scientific Officer acquired 12,376 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Humeau Laurent Chief Scientific Officer 2026-02-26 Option exercise +5,010 37,632 D: show line 1 in the form
Humeau Laurent Chief Scientific Officer 2026-02-26 Shares withheld for taxes −2,064 $1.79 $3,695 35,568 D: show line 2 in the form
Humeau Laurent Chief Scientific Officer 2026-02-26 Option exercise +7,366 42,934 D: show line 3 in the form
Humeau Laurent Chief Scientific Officer 2026-02-26 Shares withheld for taxes −3,034 $1.79 $5,431 39,900 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Humeau Laurent Chief Scientific Officer 2026-02-26 Option exercise · Restricted Stock Unit −5,010 5,009 D: show line 5 in the form
Humeau Laurent Chief Scientific Officer 2026-02-26 Option exercise · Restricted Stock Unit −7,366 14,732 D: show line 6 in the form
Loading xslF345X05/wk-form4_1772228940.xml…